Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study

Fig. 3

A Changes in SCCAI 0 clinical remission rates at baseline, week 2, and week 6 of patients who switched to budesonide foam from topical 5-ASA preparation because of residual symptoms (SCCAI ≥ 1). B Changes in clinical remission rates (SCCAI ≤ 2) at baseline, week 2, and week 6 after budesonide foam administration. C. Changes in SCCAI 0 clinical remission rates at baseline, week 2, and week 6 after budesonide foam administration for the patients with residual symptoms in clinical remission (SCCAI 1 or 2)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us